Ocular Complications Following Bone Marrow Transplant Common in Study

EMBARGOED FOR RELEASE: 3 P.M. (CT), THURSDAY, FEBRUARY 28, 2013

 

JAMA Ophthalmology Study Highlights

 

Ocular Complications Following Bone Marrow Transplant Common in Study

 

A study in the Netherlands by Viera Kalinina Ayuso, M.D., of the University Medical Center Utrecht, the Netherlands, examined the development of eye complications among children within one year of hematopoietic stem cell transplantation (HSCT, a bone marrow transplant). (Online First).

 

The study included 49 patients who had ophthalmologic evaluations before HSCT and after. The ocular complications researchers looked at included uveitis (inflammation), hemorrhagic complications, optic disc edema and dry eye syndrome (DES). A total of 13 patients (27 percent) developed an ocular complication after HSCT. The complications included DES (n=7, 14 percent), (sub) retinal hemorrhage (n=6, 12 percent) and others, according to the study results.

 

“Ocular complications in pediatric HSCT patients are common, although mostly mild,” the study concludes.

(JAMA Ophthalmol. Published online March 4, 2013. doi:10.1001/.jamainternmed.2013.2500. Available pre-embargo to the media at http://media.jamanetwork.com.)

 

Editor’s Note: This study was financially supported by some Dutch nongovernment scientific funds. Please see article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.